• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小剂量阿糖胞苷治疗急性非淋巴细胞白血病

Low dose cytosine arabinoside in the treatment of acute non-lymphoblastic leukemia.

作者信息

Insiripong S, Thaisamakr S

机构信息

Department of Medicine, Maharat Nakhon Ratchasima Hospital, Thailand.

出版信息

J Med Assoc Thai. 1996 Sep;79(9):568-71.

PMID:8996985
Abstract

Low-dose ARA-C (10 mg/m2 subcutaneous injection twice/day for 20 days with 10 days rest) was prescribed in 8 cases of newly diagnosed ANLL. Only one case attained complete remission in 2 courses and lasted for one and a half years without maintenance therapy. She was 63 years of age. The drug could be tolerated well and no serious side effect was observed.

摘要

对8例新诊断的急性非淋巴细胞白血病患者采用小剂量阿糖胞苷(10mg/m²皮下注射,每日2次,共20天,休息10天)治疗。仅1例在2个疗程后达到完全缓解,且未进行维持治疗,缓解持续了一年半。该患者63岁。药物耐受性良好,未观察到严重副作用。

相似文献

1
Low dose cytosine arabinoside in the treatment of acute non-lymphoblastic leukemia.小剂量阿糖胞苷治疗急性非淋巴细胞白血病
J Med Assoc Thai. 1996 Sep;79(9):568-71.
2
Chemotherapy for acute non-lymphocytic leukemia with low-dose cytosine arabinoside (Ara-C).低剂量阿糖胞苷(Ara-C)治疗急性非淋巴细胞白血病
Nihon Ketsueki Gakkai Zasshi. 1990 Feb;53(1):45-50.
3
[Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].[70岁以上急性髓系白血病。小剂量阿糖胞苷治疗的经验]
Sangre (Barc). 1998 Feb;43(1):35-9.
4
[Low-dose oral etoposide and subcutaneous injection of low-dose cytosine arabinoside (Et-A non i.v.) with or without minimum anthracycline for refractory acute non-lymphoblastic leukemia].[低剂量口服依托泊苷和皮下注射低剂量阿糖胞苷(非静脉注射的Et-A方案)联合或不联合最小剂量蒽环类药物治疗难治性急性非淋巴细胞白血病]
Gan To Kagaku Ryoho. 1998 Aug;25(10):1603-7.
5
Sequential standard dose mitoxantrone and cytosine arabinoside for newly diagnosed adult acute myeloblastic leukemia.序贯标准剂量米托蒽醌和阿糖胞苷用于新诊断的成人急性髓细胞白血病
Neoplasma. 1999;46(1):61-5.
6
[Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].改良FLAG方案治疗33例复发/难治性白血病的疗效
Ai Zheng. 2003 Dec;22(12):1330-3.
7
[Low-dose cytosine arabinoside (ARA-C) in the treatment of acute myeloid leukemia].
Schweiz Med Wochenschr. 1984 Dec 1;114(48):1763-6.
8
Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukemias and myelodysplastic syndromes.
J Chemother. 1989 Jul;1(4 Suppl):1276-8.
9
Mitoxantrone and cytosine arabinoside in previously untreated adult patients with acute non-lymphocytic leukemia.
Haematologia (Budap). 1996;27(2):93-7.
10
[All-trans retinoic acid combined with low-dose cytosine arabinoside treatment for acute myelogenous leukemia with trilineage myelodysplasia--a case report].全反式维甲酸联合小剂量阿糖胞苷治疗伴三系骨髓发育异常的急性髓系白血病——病例报告
Gan To Kagaku Ryoho. 2001 Mar;28(3):407-10.